Unichem's Profit After Tax Increased by 24%

Mumbai, Maharashtra, India, Friday, January 18, 2013 -- (Business Wire India) 
The Board of Directors of Unichem Laboratories Ltd at their meeting held on
January 18, 2013 approved the Third Quarter (Q3) Unaudited Results for FY
The Company recorded a total income of Rs. 232.57 Crores for the quarter ended
December 31, 2012 as against Rs. 222.62 Crores in the corresponding quarter of
the previous year recording an increase of over 4%. The Total Income for Nine
months ended December 31, 2012 increased by 25% as compared to corresponding
nine months. 
Profit after tax for the current quarter stood at Rs. 30.34 Crores as against
Rs. 24.46 crores recorded in the corresponding quarter of the previous year
showing an increase of 24%. Profit after tax for nine months ended December 31,
2012 increased by 66% as compared to corresponding nine months. 
About Unichem Laboratories Limited 
Unichem Laboratories Limited is an International, integrated, speciality
pharmaceutical Company. It manufactures and markets a large basket of
pharmaceutical formulations as branded generics as well as generics in India and
several other markets across the world. In India, the Company is a leaded in
niche areas of cardiology, neurology and other orthopadics and anti-infectives.
The Company has strong skills in product development, process chemistry and
manufacturing of complex API as well as dosage forms. 
More information about the Company can be found at www.unichemlabs.com. 
BSE: 506690; NSE: UNICHEMLAB; Reuters: UNLB.BO; Bloomberg: UN@IN 
Media contact details 
Mr. M Gundu Rao,
Unichem Laboratories Limited,
+91 9820228944 / +91 (22) 66888380,
Mr. Rakesh Parikh,
Unichem Laboratories Limited,
+91 9892925555 / +91 (22) 66888414,
Mr. K Subharaman,
Unichem Laboratories Limited,
+91 9833031121 / +91 (22) 66888404,
Contributed via: Bloomberg Publisher WEB Service 
Provider ID: d121de9f5c114b4194d21b8a5fd250aa 
-0- Jan/21/2013 04:53 GMT
Press spacebar to pause and continue. Press esc to stop.